Marketing
Marketing: Ready for the Next War?
Like many armies, pharma marketing organizations are usually better equipped to fight the last war rather than the next one. But success, in war and in marketing, usually goes to the side that accepts and acts on the challenges of the new environment more rapidly, writes Faruk Capan...Read more
Sales
What's Wrong with the Annual Sales Kickoff… And How to Fix It
As we turn the page to 2015, the season of annual sales meetings is upon us. Sales teams look to these national gatherings to address mounting in-market challenges—from diminished physician access and cross-selling demands to heightened regulatory and competitive pressures...Read more
Emerging Markets
Indonesia’s Promise for 2015
Indonesia is expected to be the one of the most promising markets for pharma in 2015, thanks to its new healthcare insurance scheme Jaminan Kesehatan Nasional (JKN), according to Reenita Das, partner and senior vice president of Healthcare & Life Sciences at Frost & Sullivan ...Read more
Healthcare Reform
Key Obamacare Actions for Rx Manufacturers in 2015
At first glance Obamacare developments for the American Rx industry in 2015 appear fairly benign. However, digging deeper suggests that each, in its own way, could cause various actions with potential for substantial uncertainty for the U.S. pharmaceutical industry next year. If your response to this profound observation was, “Really, what’s new?” then read on ...Read more
| 
